Canine cancer vaccine in development could see wide distribution

02/28/2012 | FloridaTrend.com

Florida-based company Morphogenesis developed a canine lymphoma cell-processing treatment, a process in which tumor cells become a target for the immune system by being labeled with a bacterial protein. Researchers at Morphogenesis are now developing a vaccine from stock cells instead of using a patient's own tumor cells, which could allow the treatment to become widely available.

View Full Article in:

FloridaTrend.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC